InvestorsHub Logo
Followers 58
Posts 10383
Boards Moderated 1
Alias Born 09/21/2016

Re: georgejjl post# 410954

Friday, 04/14/2023 5:13:00 PM

Friday, April 14, 2023 5:13:00 PM

Post# of 473046
georgejji

I have heard and believe that JNJ, Pfizer and Merck among other big Pharma are also interested in Anavex Life Sciences.



What you suggest makes a lot of sense if AVXL&(other pharma's w/active CNS indication specific app candidates drugs) were able to work w/AVXL and to apply AI Bio-tool suites and evaluate AVXL S1R MOA to their indication specific app..

My thinking is that when they evaluate A2-73 (etal) further they get the best of both worlds, they apply their own customized Bio w/AVXL S1R Bio-MOA for an effective indication specific solution. They then get to claim a new-effective product/retain NDA ownerships while delivering an effective CNS pro0duct. Everyone wins, including CNS patients.

IMO, that is what we have here , a limitless opportunity. This also ties well w/the news on org. structural change
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News